Health Velocity Capital
Health Velocity Capital is a healthcare-focused venture capital firm that invests in innovative healthcare software and services companies, partnering with strategic limited partners (insurers, health systems, PBMs) and global institutional investors to provide portfolio companies with capital, customer introductions, and operating support.
- Company typePrivate
- Founded2016
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Health Velocity Capital does
Health Velocity Capital is a healthcare-focused venture capital firm that invests exclusively in innovative healthcare software and services businesses. The firm targets companies that create entirely new markets or redefine existing healthcare categories, with a stated emphasis on affordability, sustainability, and consumer-friendliness. Founded circa 2014 and headquartered in San Francisco with a secondary office in Brentwood, Tennessee, the firm is led by co-founders and managing partners Bruce Crosby and Saurabh Bhansali, alongside managing partner Marty Felsenthal.
The firm does not develop proprietary technology products. Its core offering is an investment fund coupled with value-add services for portfolio companies, including customer introductions, board and team placements, sales and marketing strategy, capital raise strategy, and advisory board development. A defining feature is its strategic limited partner base: health insurers covering 175 million Americans, health systems operating 700+ hospitals, and pharmacy benefit managers serving 75%+ of the nation, supplemented by global institutional investors and 100+ senior healthcare executives who invest personally. The firm runs proprietary engagement programs including an annual Strategic LP Innovation Survey, quarterly thematic white papers, and an annual JPMorgan Healthcare Conference Innovation Reception.
Health Velocity Capital generates revenue through the standard VC economics of management fees (typically 1.5–2% of committed capital) and carried interest (~20% of profits above the hurdle) on its funds. As of the most recent disclosure period the firm has 21 active portfolio companies and 1–10 employees, consistent with a boutique partnership model. Notable recent investments include leading Third Way Health's $15M Series A (2026) and Hummingbird Healthcare's $20M Series B (2025), and participating in Artera's $65M growth round (2025) and Vanna Health's $17M round (2026). Realized exits include Teladoc, Livongo, Change Healthcare, MDLive, Contessa, Zipari, OnShift, Aspire, Three Oaks Hospice, and Headspace Health.
Health Velocity Capital firmographics
Firmographics- Name
- Health Velocity Capital
- Legal name
- Health Velocity Capital
- Website
- https://healthvelocitycapital.com/
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Health Velocity Capital is a healthcare-focused venture capital firm that invests in innovative healthcare software and services companies, partnering with strategic limited partners (insurers, health systems, PBMs) and global institutional investors to provide portfolio companies with capital, customer introductions, and operating support.
- Ownership category
- akta.pro rank
Health Velocity Capital industry classification
Industry- Product category
- Venture Capital / Healthcare Investment
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Health Velocity Capital is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Health Velocity Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Fund Management / Management Fees: VC firms typically charge management fees (usually 1.5-2% of committed capital) on the funds they manage.
- Carried Interest (Carry): VC firms earn carried interest (typically 20% of profits above the hurdle rate) when portfolio companies are sold or go public at a profit.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels9 records
Health Velocity Capital product offering
Product offeringCore offering
Health Velocity Capital is a healthcare-focused venture capital firm that invests exclusively in innovative healthcare software and services businesses. The firm raises capital from strategic limited partners (health insurers, health systems, pharmacy benefit managers) and global institutional investors, then provides portfolio companies with customer introductions, strategic guidance, and access to an extensive healthcare executive network to accelerate adoption and revenue growth.
Product overview
Health Velocity Capital operates as a venture capital investment firm, not a product company. It does not offer a unified platform or SaaS product. The firm provides an investment fund that finances innovative healthcare software and services companies, along with value-add services including strategic guidance, customer introductions, and team building support to its portfolio companies. The firm's portfolio spans 35+ companies across various healthcare technology and services segments including telemedicine, mental health, behavioral health, healthcare navigation, cybersecurity, and care management. The investment approach focuses on companies creating new markets in affordable, sustainable, and consumer-friendly healthcare.
Differentiator
Problem solved
Functional benefit
Products and services
- Health Velocity Capital Investment Fund A venture capital fund that invests exclusively in innovative healthcare software and services businesses creating affordable, sustainable, and consumer-friendly healthcare solutions. The fund is backed by strategic limited partners including healthcare insurers, health systems, and pharmacy benefit managers, alongside global institutional investors.
- Portfolio Company Network Services Value-add service offering that provides portfolio companies with strategic guidance, customer introductions to healthcare insurers, health systems, and PBMs, board and team member placements, sales and marketing strategy, capital raise strategy, and Advisory Board development support.
Quantifiable outcome
- More than 95% of partnered companies received tangible equity value through network introductions
- +1 more outcomes
Companies that use Health Velocity Capital
Customer profileNamed customers19 records
Segments1 record
Ideal customer profiles1 record
Health Velocity Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Health Velocity Capital partnerships and signals
Strategic signalScale indicators7 records
Recent moves5 records
Expansion highlights4 records
Health Velocity Capital competitors and assessment
Company assessmentBroad incumbents
- Optum Ventures: CVC arm of UnitedHealth/Optum that invests in healthcare technology and services companies, leveraging the Optum payer-provider platform. Comparable as a strategic LP-backed healthcare investor with deep distribution into insurers and providers.
- General Catalyst: Multi-stage VC with a significant healthcare practice (including the HATCo/Summit Health platform). Directly competes for healthcare software/services deals and offers strategic operating support similar to Health Velocity's LP model.
- Andreessen Horowitz (Bio/Health): Large multi-stage firm with a dedicated bio/health fund investing in healthcare software, services, and biotech. Competes for the same healthcare software and services opportunities and provides similar operating support.
- New Enterprise Associates (NEA): Large multi-stage firm with one of the most active healthcare investment practices, including payer, provider, and digital health. Overlaps with Health Velocity on stage, themes, and value-add orientation.
- Bessemer Venture Partners: Multi-stage venture firm with a deep healthcare franchise and dedicated healthcare team. Competes for the same growth-stage healthcare software and services deals and offers similar board-level support.
Direct peers
- Oak HC/FT: Specialist healthcare and fintech venture and growth firm investing across payer, provider, and health IT. Closest comparable as a dedicated, sector-specialist healthcare investor at venture and growth stages.
- Venrock: Long-tenured healthcare-focused VC investing across payer, provider, and digital health. Directly comparable as a specialist investor with deep healthcare roots and a track record of category-defining investments.
- Flare Capital Partners: Dedicated healthcare technology venture firm investing across payer, provider, and care delivery. Closely comparable specialist with similar stage focus and strong LP-side strategic relationships.
- Echo Health Ventures: Strategic healthcare venture platform formed by Cambia Health Solutions and Mosaic Health Solutions, investing in payer, provider, and consumer health. Direct peer as a strategic-LP-driven, sector-focused healthcare investor.
- Define Ventures: Early-to-growth healthcare venture firm focused on digital health, payer/provider technology, and care delivery. Highly comparable as a healthcare-specialist VC with similar stage orientation and operating playbook.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks4 records
Key highlights6 records
Customer concentration
Health Velocity Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Health Velocity Capital leadership team
Management profileNumber of profiles
Profiles4 records
Health Velocity Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Health Velocity Capital M&A and investment
M&A and investmentM&A
Investments40 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Health Velocity Capital
What does Health Velocity Capital do?
Health Velocity Capital is a healthcare-focused venture capital firm that invests exclusively in innovative healthcare software and services businesses. The firm raises capital from strategic limited partners (health insurers, health systems, pharmacy benefit managers) and global institutional investors, then provides portfolio companies with customer introductions, strategic guidance, and access to an extensive healthcare executive network to accelerate adoption and revenue growth.
Is Health Velocity Capital a public or private company?
Health Velocity Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Health Velocity Capital founded?
Health Velocity Capital was founded in 2016. It employs 1 to 10 people.
Where is Health Velocity Capital based?
Health Velocity Capital is headquartered in San Francisco, United States, in the North America region.
How does Health Velocity Capital make money?
Two revenue lines are on record. Fund Management / Management Fees are the primary driver. The others are carried Interest (Carry).
Who are Health Velocity Capital's main competitors?
Broad incumbents on record are Optum Ventures, General Catalyst, Andreessen Horowitz (Bio/Health), New Enterprise Associates (NEA) and Bessemer Venture Partners. Direct peers are Oak HC/FT, Venrock, Flare Capital Partners, Echo Health Ventures and Define Ventures.
Does Health Velocity Capital have an API?
No public API is recorded for Health Velocity Capital.
What industry is Health Velocity Capital in?
Health Velocity Capital's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.